Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1717095

registered interest
date	10/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ritlecitinib: Shropshire
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when she expects Litfulo to be made available to NHS patients in (a) Shropshire, (b) Telford and (c) Wrekin.
tabling member constituency	The Wrekin
tabling member printed	Mark Pritchard
uin	25645
answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>The National Institute for Health and Care Excellence (NICE) makes recommendations on whether all new licensed medicines should be routinely funded by the National Health Service, based on an assessment of their costs and benefits.</p><p>On 27 March 2024, NICE published final technology appraisal guidance recommending ritlecitinib (Litfulo) for treating severe alopecia areata in people 12 years old and over. The NHS in England is legally required to fund medicines recommended by NICE within three months of the publication of its final guidance.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 14/05/2024 16:53:44 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1576 label Biography information for Mark Pritchard

1717160

registered interest
date	10/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Joint Replacements: Post-operative Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that best practice guidelines for prosthetic infection are implemented across elective surgery clinical care pathways.
tabling member constituency	Hayes and Harlington
tabling member printed	John McDonnell
uin	25605
answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>The Government is working with NHS England to improve perioperative care. This should ensure best practice guidelines are implemented across surgery clinical care pathways, including for prosthetic infections. In May 2023, NHS England published guidance setting out five core perioperative care requirements relating to the care of adult patients awaiting planned inpatient surgery. These measures address the key objective of identifying health needs as early as possible in perioperative pathways, and then using time on the waiting list to optimise health. The NHS England National Elective Recovery and Outpatients programme is working with NHS England regional teams to help oversee and support compliance, and will continue to do so throughout 2024/25.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 14/05/2024 16:56:42 answering member 4044 label Biography information for Andrew Stephenson
tabling member	178 label Biography information for John McDonnell

1716489

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Steroid Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the implications for her policies of the long term prescribing of topical corticosteroids.
tabling member constituency	Morley and Outwood
tabling member printed	Dame Andrea Jenkyns
uin	25275
answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>In 2021 the Medicines and Healthcare products Regulatory Agency conducted a review and concluded that, when used appropriately, topical corticosteroids are a safe and effective treatment, and they continue to monitor the safety of these products. No further assessment has been made.</p><p>When making prescribing decisions for their patients, clinicians are expected to take into account best prescribing practice, in this case on the use of topical corticosteroids, alongside local commissioning decisions. The National Institute for Health and Care Excellence has made a number of recommendations on the use of topical corticosteroids in guidelines, on topics such as atopic eczema in under 12-year-olds, and psoriasis.</p><p>It is for the general practitioner or other responsible clinician to work with their patient and decide on the best course of treatment, with the provision of the most clinically appropriate care for the individual always being the primary consideration.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 14/05/2024 17:01:00 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4490 label Biography information for Dame Andrea Jenkyns

1716528

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Professions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help ensure public (a) safety and (b) clarity in the healthcare roles of (i) physician associates and doctors and (ii) other NHS staff.
tabling member constituency	South Swindon
tabling member printed	Sir Robert Buckland
uin	25215
answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>The introduction of regulation by the General Medical Council (GMC) will provide a standardised framework of governance and assurance for the clinical practice and professional conduct of Anaesthesia Associates (AAs) and Physician Associates (PAs), and make it easier for employers, patients, and the public to understand the relationship between these roles and that of doctors.</p><p> </p><p>Whilst statutory regulation is an important part of ensuring patient safety, it is also achieved through robust clinical governance processes within healthcare organisations, which are required to have systems of oversight and supervision for their staff.</p><p> </p><p>NHS England is working with the relevant professional colleges and regulators to ensure the use of associate roles is expanded safely and effectively, and that they are appropriately supported, supervised, and integrated into multidisciplinary teams. NHS England has written to trusts to remind them of their responsibilities in this area, with further information available at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/long-read/ensuring-safe-and-effective-integration-of-physician-associates-into-departmental-multidisciplinary-teams-through-good-practice/" target="_blank">https://www.england.nhs.uk/long-read/ensuring-safe-and-effective-integration-of-physician-associates-into-departmental-multidisciplinary-teams-through-good-practice/</a></p><p> </p><p>We are clear that AAs and PAs are not, and should never be, referred to as medical practitioners, doctors, or consultants. It is the responsibility of professionals and their employers to ensure professional titles are used appropriately. As set out in the National Institute for Health and Care Excellence’s guidelines, all healthcare professionals directly involved in a patient's care should introduce themselves and explain their role to the patient. The GMC has published interim standards for AAs and PAs in advance of regulation, which make it clear that professionals should always introduce their role to patients and set out their responsibilities in the team.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 14/05/2024 16:54:09 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4106 label Biography information for Sir Robert Buckland

1716531

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Surgery: Waiting Lists
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of surgical hubs on trends in waiting times for elective care.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	25260
answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>Several external evaluations of the impact of Elective Surgical Hubs are currently ongoing, and supported by NHS England. The University of York is carrying out a comprehensive evaluation funded by the National Institute of Healthcare Research.</p><p> </p><p>The Health Foundation’s Improvement Analytics Unit has also conducted a quantitative assessment of the impact of surgical hubs, with the results to be published later this month. The Health Foundation’s analysis will indicate the impact surgical hubs have had on the number of procedures undertaken and whether they have increased day-case rates and reduced lengths of stay, all of which supports elective recovery, and reductions in waiting times for elective care.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 14/05/2024 17:03:09 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4471 label Biography information for Rachael Maskell

1716538

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she is taking steps to promote asthma research through the use of (a) data and (b) AI.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	25267
answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>The Department funds research on health and social care through the National Institute for Health and Care Research (NIHR). The NIHR welcomes funding applications for research into any aspect of human health, including asthma. The NIHR Respiratory Translational Research Collaboration has a dedicated asthma theme which includes research on diagnostics, monitoring, and digital health interventions to manage asthma. The NIHR has further encouraged research using data science and artificial intelligence approaches through the Artificial Intelligence in Health and Care Award, jointly funded with NHS England and the NHS Accelerated Access Collaborative since 2020.</p><p>We also note that the National Institute for Health and Care Excellence’s (NICE’s) guideline committee made several recommendations on diagnosing and monitoring asthma, and for managing chronic asthma when the 2017 guideline was published. A further new recommendation for research was made when the guideline was updated in 2020. It is therefore possible that the NICE will make further recommendations for research when its updated asthma guideline is published later this year.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 14/05/2024 17:05:31 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4471 label Biography information for Rachael Maskell

1716539

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Digital Technology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help patients with the technological management of asthma.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	25268
answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>There are a range of technologies available to help people manage their asthma. It is important that people are given the necessary support to use technology in managing their conditions, provided these tools have strong levels of evidence, and appropriate regulatory approval, for instance the UK Conformity Assessment, the Conformité Européenne, or compliance with the NHS Digital Technology Assessment Criteria. NHS England and the National Institute for Health and Care Excellence (NICE) are exploring the potential for the platforms for the digital self-management of asthma to be evaluated, although this is dependent on the technology readiness level, which would require good levels of evidence and appropriate regulatory approval. Guidelines developed jointly by the NICE, the Scottish Intercollegiate Guidelines Network, and the British Thoracic Society to harmonise the recommendation from each organisation are ongoing, and have an expected publication date of 30 October 2024.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 14/05/2024 17:12:16 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4471 label Biography information for Rachael Maskell

1716564

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she plans to take to ensure those that don't have access to the internet can respond to the 10 year review of the NHS constitution.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	25355
answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>The Department is committed to supporting people from all backgrounds in accessing the NHS Constitution consultation. We would encourage those without internet access to utilise resources on offer at some public spaces, including libraries and community centres, to support their response. The easy read consultation, which will be launched imminently, will provide an option for the consultation to be printed and sent to the Department. More widely, the Government has taken steps to ensure households across the United Kingdom are able to access fast, reliable mobile and broadband services to support their full participation in society.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 14/05/2024 17:01:13 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4769 label Biography information for Daisy Cooper

1716573

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to reduce waiting times for cancer (a) diagnosis and (b) treatment in Merseyside.
tabling member constituency	Liverpool, West Derby
tabling member printed	Ian Byrne
uin	25386
answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>The Department is taking steps to reduce cancer diagnosis and treatment waiting times across England, including Merseyside. The Government is working jointly with NHS England on implementing the delivery plan for tackling the COVID-19 backlogs in elective care, and plans to spend more than £8 billion from 2022/23 to 2024/25 to help drive up and protect elective activity, including cancer diagnosis and treatment activity. Additionally, as outlined in the 2024/25 NHS England Planning Guidance, NHS England are providing over £266 million in cancer service development funding to Cancer Alliances to support delivery of the operational priorities for cancer.</p><p>The latest published cancer performance data for Cheshire and Merseyside Integrated Care Board (ICB) shows that in March 2024, 76% of patients referred met the Faster Diagnosis Standard (FDS), which aims to ensure patients have cancer diagnosed or ruled out within 28 days of referral from a general practice or screening services. This surpasses the 75% standard and shows an improvement of 5.8% since March 2023.</p><p>Similarly, the latest performance data for Cheshire and Merseyside ICB shows that of those referred for cancer treatment in in March 2024, 92.4% met the 31-day wait from a decision to treat to first or subsequent treatment of cancer combined standard, and 75.4% met the 62-day referral to first definitive treatment for cancer combined standard. According to data from NHS England, this is above national cancer performance for both treatment standards.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 14/05/2024 16:41:32 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4831 label Biography information for Ian Byrne

1716574

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to increase the proportion of people of people who are treated within 62 days of referral for cancer treatment.
tabling member constituency	Liverpool, West Derby
tabling member printed	Ian Byrne
uin	25387
answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>The Department is taking steps to reduce cancer diagnosis and treatment waiting times across England, including the time between an urgent general practice referral and the commencement of treatment for cancer for patients. The Government is working jointly with NHS England on implementing the delivery plan for tackling the COVID-19 backlogs in elective care, and plans to spend more than £8 billion from 2022/23 to 2024/25 to help drive up and protect elective activity, including cancer diagnosis and treatment activity. Additionally, as outlined in the 2024/25 NHS England Planning Guidance, NHS England is providing over £266 million in cancer service development funding to Cancer Alliances, to support delivery of the operational priorities for cancer.</p><p>To help achieve the cancer waiting times standards, NHS England is streamlining cancer pathways. This includes implementing non-symptom specific pathways for patients who present with non-specific symptoms, as well as timed cancer pathways focused on the most challenged pathways, such as lower gastrointestinal and skin cancer. The pathways aim to support improvements in operational performance and patient experience, as well as providing models to support sustainable improvement.</p><p>Furthermore, to improve cancer treatment we are maximising the pace of the roll-out of additional diagnostic capacity. We are currently delivering the second year of the three-year investment plan for establishing community diagnostic centres (CDCs). We are ensuring timely implementation of new CDC locations and upgrades to existing CDCs, with capacity prioritised for cancer diagnostics. As of April 2024, 160 CDCs are operational, and have delivered almost 8 million tests, checks, and scans since July 2021. Additionally, we are supporting advances in radiotherapy. Since 2016, we’ve invested £162 million into cutting-edge radiotherapy equipment to replace or upgrade over 100 radiotherapy treatment machines.</p><p>We are committed to delivering the best possible outcomes for patients, and our approach is seeing success. Almost 344,000 people received their first cancer treatment in the 12 months to March 2024. Further, 2023/24 is the best year so far for the Faster Diagnosis Standard (FDS), with the latest performance data showing that NHS England hit the FDS target for the second month in a row at 77.3%, above the standard of 75%. We have also reduced the 62 day or over cancer referral to treatment backlog, to pre-pandemic levels.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 25388 25389 question first answered 14/05/2024 16:43:49 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4831 label Biography information for Ian Byrne